Get startedLog in
    Picture of Pfizer logo

    PFIZER — Pfizer Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Pfizer, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue22,38626,11024,24821,93222,814
    Cost of Revenue
    Gross Profit13,79816,02314,97113,51214,709
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses16,25218,79416,80316,01816,019
    Operating Profit6,1337,3167,4445,9146,794
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes6,6877,7298,2407,46110,161
    Provision for Income Taxes
    Net Income After Taxes4,9766,1266,2395,5137,676
    Net Income Before Extraordinary Items
    Net Income4,9766,1266,2395,5137,676
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income4,9766,1266,2395,5137,676
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS108133131120139
    Dividends per Share
    Special Dividends per Share